Lymphoid Leukemia — Trials

Lymphoid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 827
Recruiting: 465
Ph III recruiting: 43
Growth YoY: −7.8%
Industry share: 18%
Top sponsor: City of Hope Medical Center
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (489)

clinicaltrialsPublishedShowing 101–115 of 115 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02810223	Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia	unknown	Phase 1	20	Beijing Sanwater Biological Technology Co., Ltd.INDUSTRY	1	Oct 14, 2016	clinicaltrials
NCT02456350	Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies	unknown	Phase 1	36	Shenzhen Second People's HospitalOTHER	1	Aug 3, 2016	clinicaltrials